¬x¤k¤h¡A28¦~¦¸¡Aªì¶E 105¦~5¤ë¡A¦å²G³zªR¥v¤T¦~¡A3¦¸¡þ©P¡A¤´¦³§¿¡A¨C¤é§¿¶q¬ù200cc¡A«å¡B¯Ç®t¡B©ö³Ý¡CAlk-P:60-80¡AALT: 15-20¡AAST:10-15¡AGlucose AC:105-120¡ABUN:45-55¡AUA:4.5-5.5¡ACr:7.35-8.20¡AAlb:4.0-4.3¡ACho:180-240¡ATG:107-140¡ACa:9.5-9.6¡AP:3.6-4.4¡ANa:140-145¡AK:4.0-4.5¡ARBC:2.93-3.08¡AHb:9.0-9.5¡AWBC:8000-8500¡APlt:145-199¤d¡C
³B¤è¡G·íÂk¡B°®Á¤¡Bªþ¤l¡B¶À¬f¡B½Þd¡BÓ¬d¡B»a¥º¡B¿AÂm¡B¥É®Û¤l¡B¶À¯Ï¡B¤Hçx¯»¡B¤t¤C¯»¡C(¯»ÃÄ¥tªA) ¤C©«¡C
¤G¶E: ¨ä¤k¨à§iª¾¡AªA¤WÃī᧿¶qÁö¦³¼W¥[¡A¦ý©âµ¬±¡§ÎÄY«¡C
³B¤è: ¤@¡BÅñ: µÇ¹LÂo¥\¯àYºCºC«ì´_¡A³zªR®É¶¡¥²¶·«·spºâ¡C
¤G¡Bì¤è§ï¥Î¬ì¾Ç¤¤Ãį»¡A¦ý¤Hçx»P¤t¤C¤´ºû«ù¥ÍÃį»¥½²V¤J¡C
¤G¶E¥H«á¡A§¡±Ä¥Î¬ì¾Ç¤¤ÃÄ¥[¤Hçx¤t¤CÄòªA¡Aµø±¡ªp½Õ¾ã¡A¦p«K¯µ¡A¥[¤j¶À¡B¬f¤l¤¯¡A¸y¸}µmµh¡A¥[¤û½¥¡B§ù¥òµ¥¡AÄòªA¦Ü106¦~©³¡C«á¦]Âå®vÓ¤H¦]¯À°±ÃÄ¡]Äw³Æ¶E©Ò¡^¡C«á©ó107¦~6¤ë¤~¤S¶}©lªA¥Î¤¤Ãį»¡A¦ý¥ÎÃĤ¤Â_³o¥b¦~¨Ó¡A¨C¤éªº§¿¶q¥Ñ200cc±¼¦Ü50 cc¡A¥B§¿¯ä¨ý«¡C³B¤è¨ÌÂÂ¥H¬ì¤¤Ãį»¤d´²¥[¸É¶§¸É®ðÃÄ¡A¦AÀH¯g¥[´î¡C¤§«á§¿¶q¨ÃµL«ì´_¡A¦ý§¿¯ä¨ý´î»´¡C
쥻¥Î¤ô·Î¾¯ªvÀøªº´Á±æ¡A¬O¬ß¯à±N3¦¸¡þ¶gªº³zªR¦¸¼Æ°¬°2¦¸¡þ¶g¡A¥H´£°ª¥Í¬¡«~½è¡CÁöµM¡A¬Û¸û¹ê»ÚµÇŦ24¤p®É¤£°±ªº¹B§@¼Ò¦¡¡A¤H¤u³zªRªºÀW²v¬O¶V±K¶°¶V¦n¡A¥NÁ¼oª«¤@²£¥X¥i¥H¨³³t±Æ¥XÅé¥~¡C³o¤¤¶¡¦p¦ó¨ú±Ë¦³«Ý¤¤¡þ¦èÂå¥Í¦@¦P§V¤O¨Ó°t¦X¡C¨Ì·Ó°ê»Ú¶¡ªº¦@ÃÑ¡A°£¤F¨C¤Ñ¤p«K¤@©wn¤j©ó 500²@¤É¥~¡A¤U¦C 9¶µ±ø¥ónºÉ¥i¯à²Å¦X¡A¤~¾A¦X¨C¶g³zªR¤G¦¸¡C¨Ã¥B¡A¨CÓ¤ë»Ýn«·sµû¦ô¡CY¤p«K¶q¡BÀç¾i¡B¾ãÅé°·±dª¬ªp¨«¤U©Y¡A´N»Ý§ï¬°¼Ð·Çªº¨C¶g¤T¦¸³zªR¡C
1. §ï¬°¤@¶g³zªR¤G¦¸®É¡A³zªR¶¡Å髼W¥[¤p©ó2.5¤½¤ç¡]©Î¤p©ó 5 %ªº°®Åé«¡^¡C
2. ¦³¤ßªÍ¯e¯fªÌ¡A»Ý±±¨î¨}¦n¥BéwµL©úÅã¯gª¬¡A¦p¤ô¸~¡B¯Ý´e©Î®ð³Ý¡C
3. Å髬¶V°ª¤jªÌ¡A¶V»Ý¦³§ó¦h´Ý¾lµÇ¥\¯à¡A¤~¾A¦X¤@¶g³zªR¤G¦¸¡C
4. ¦å¹[±±¨î±o©y¡]K¤p©ó5.5 mEq / L¡^¡C
5. ¦åÁC±±¨î±o©y¡]P¤p©ó5.5 mg / dL¡^¡C
6. Àç¾i¤Î¥NÁ¨}¦n¡A¨Åé¨S¦³²§±`ªº°ª¶q¥NÁ¡A¦p´c¯fÅé½è¡B§¿¯À´á¹L°ª¡B±Ñ¦å¯gµ¥¡C
7. ¦å¦â¯À¸gªvÀø«á¦Ü¤Ö 8 g / dL¡C
8. ¦@¯f¯g¤£¦h©Î±±¨î¨}¦n¡C
9. ¥Í¬¡«~½è¨}¦n¡C
Á{§É¤W¡A±`¨Ï¥Î¡m¶Ë´H½×¡n¤¤ªº¤d´²¨ÓªvÀø¯B¸~¡B§¿¶q´î¤Öµ¥«æ¡þºC©ÊµÇª¢©ÎµÇ¯fÅÜ¡CY³B©ó°ª´áȦå¯g¬Æ©Î§¿¬rªº¶¥¬q¡A¥H¤¤ÂåªvÀø¤[¯fªºÆ[ÂI¡A·|¥[¤J¸ÉµÇ¶§ªºÃÄ«~¡A¦p°®Á¤¡Bªþ¤lµ¥¡A¦¹®É¡A¤d´²¤¤ªº®ÛªK¤]n§ï¦¨¦×®Û©Î¥É®Û¤l¡Cªþ¤l¦]¬°ÃÄ©Ê·¥¯P¡A¥B¥«±¤W«~½è¡þ¬¶»sªº¤è¦¡¨}²û¤£»ô¡A¥²¶·¿ï¾Ü¥i¾aªº¨Ó·½¡]¤¯¦³°ó±Ä¥Î²øªQºa¦w¥þÃħ÷--»sªþ¤l¡^¡C¶À¯Ï¬°¤@±`¥Î¸É®ðÃÄ¡A¤J¤è¾¯¦Ü¤Ön¥Î¨ì¤@¨â¥H¤W¡A¥Øªº¬O¬°¤F¼W¥[µÇŦªº¨Ñ¦å¡A¦ý¤]¤£©y¬ðµM¥[¤j¾¯¶q¡A¥H¨¾Ãz½Ä¡C±q¦¹¯f¨Ò¤¤¤]¥iµo²{¡A¤@¶}©l¨Ï¥Î¤ô·Î¾¯¡Aªº½T·|¦]µÇŦªºÄéª`¼W¥[¦Ó¨Ï§¿¶q¼W¦h¡AY¦¹®É²æ¤ôªº®É¶¡¥¼¯à¬Û¹ï´î¤Ö¡A«h³y¦¨¹q¸Ñ½è¬y¥¢¦Ó©âµ¬¡C¤§«á±Ä¥Î¬ì¾Ç¤¤Ãį»§@¬°¸û«O¦uªºªvÀø¡A¦ý¶È¯àºû«ù¦í²{ªp¡A¦]ÃĤO¥¼¶e¡A¥HP§¿¶q¶È¯àºû«ù¦Ó¤w¡C¦ý³o¹ï©ó¬~µÇ±wªÌ¦Ó¨¥¡A¯à°÷ºû«ù´Ý¾lªºµÇ¥\¯à¤wÄݤ£©ö¡C
2015¦~¡A®É¥ô¥xÆWµÇŦ¯fÂå¾Ç·|¥D©e¡B°ª¶¯Âå¾Ç¤j¾Çªþ³]¤¤©M¬ö©ÀÂå°|¡]°ªÂå¡^ªº¶À©|§Ó¥D¥ô¡A¦b°ê»Úª¾¦WµÇŦÂå¾Ç´Á¥Z¡mKidney International¡nµoªí¤F¤@½g°w¹ï°·«O¸ê®Æ®w¶i¦æ¤ÀªRªºµ²ªG¡A¨ä¤º®e«ü¥X¡A¸g¹L´£·Ò¿@ÁYªº¬ì¾Ç¤¤ÃÄ¡A¹ïµÇŦ¯e¯f¬O¦³À°§Uªº¡A¬Æ¦Ü¬Y¨Ç¬ì¾Ç¤¤ÃĹïµÇŦ¨ã¦³«OÅ@§@¥Î[1]¡CÁöµM¡A³o¹ï¤¤Âå¬O¶µ¹ª»R¡AªÈ¥¿¤F¦h¦~¨Ó¤@ª½³Q¦¾¦W¤Æ¤¤ÃĦY¦h¤F·|¬~µÇªº¨èªO¦L¶H¡A¦ý§Ú̧ó§Æ±æ°µ¨ìªº¬O¡A¯à°÷±NºC©ÊµÇŦ¯f´Á§O¤Öªº±wªÌ¡A«ì´_¨ä¥\¯à¡A¤¤¥½´Áªº±wªÌ¡A¯à°÷ºû«ùª¬ªp¤£´c¤Æ¡C
°Ñ¦Ò¸ê®Æ¡G
1. Lin MY¡A Chiu YW¡A Chang JS¡A Lin HL¡A Lee CT¡A Chiu GF¡A Kuo MC¡A Wu MT¡A Chen HC¡A Hwang SJ. Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease. Kidney Int. 2015 Dec;88(6):1365-1373. doi: 10.1038/ki.2015.226. Epub 2015 Aug 5.
|